2019 Volume 31 Issue 1 Pages 16-21
Background: This study aimed to evaluate the survival impact of surgical resection among patients with pulmonary metastases from bone and soft tissue sarcomas.
Patients and Methods: We retrospectively reviewed 29 consecutive patients with ≤5 pulmonary metastases from bone and soft tissue sarcomas. The patients included 17 men and 12 women, with a median age of 66.0 years and a median follow-up of 19 months. We analysed the oncological outcome between patients who underwent surgical or non-surgical treatment.
Results: Eighteen patients underwent surgery and 11 patients did not undergo surgery. The surgery group had a 3 and 5-year overall survival rate of 64% and 58%, respectively. None of the patients in the non-surgery group survived to 3 years. Relative to the non-surgery group, surgery provided significantly better 3-year and 5-year overall survival rates.
Conclusion: Pulmonary metastasectomy may improve the prognosis of patients with pulmonary metastases from bone and soft tissue sarcomas.
